Delivering Patient-Centric Care in Assessing Mild Traumatic Brain Injury Through Novel Brain Biomarkers

Explore the latest advancements in assessing mild Traumatic Brain Injury (mTBI) through novel brain biomarkers in this informative 58-minute webinar presented by Dr. Martina Pavletić and Dr. Ksenia Musaelyan. Gain insights into the crucial need for objective rule-out tools in Traumatic Brain Injury cases to reduce unnecessary CT scans and improve emergency department efficiencies. Learn about the importance of brain biomarkers in addressing unmet needs for objective evaluation of suspected traumatic brain injuries. Discover how the introduction of novel neurological biomarkers in patient care pathways can provide an objective rule-out tool and help optimize resource allocation. Benefit from Dr. Pavletić's firsthand experience as the head of an Emergency Department and Dr. Musaelyan's expertise in neuropsychiatric disease biomarkers and drug discovery. Understand the global impact of TBI as the leading contributor to death and disability among trauma-related injuries and the limitations of current neurocognitive assessments.